Molecules/ABATACEPT

ABATACEPT

Molecular Identity

ProteinApprovedFirst approved 2006

Mechanism of action: T-lymphocyte activation antigen CD86 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ABATACEPTABATACEPT (GENETICAL RECOMBINATION)ABATACEPT RECOMBINANTBMS-188667CTLA4-IGG4MORENCIAORENCIA CLICKJECTRG-1046RG-2077

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to ABATACEPT

Loading drug network...